Literature DB >> 31589293

Clinical Situation, Therapy, and Follow-Up of Adult Craniopharyngioma.

Klaus Christian Mende1, Teresa Kellner1, Stephan Petersenn2, Juergen Honegger3, Rocío Evangelista-Zamora3, Michael Droste4, Guenter Stalla5, Timo Deutschbein6, Yawen Wang7, Dag Moskopp7, Ulrich Knappe8, Katharina Schilbach9, Joerg Flitsch1.   

Abstract

CONTEXT: Craniopharyngioma is a rare neoplastic entity of the central nervous system. Childhood-onset craniopharyngioma is the subject of frequent research whereas the information on adult-onset craniopharyngioma is scarce.
OBJECTIVE: The objective of this study was to examine the level of daily impairment in adult patients suffering from craniopharyngioma.
DESIGN: Noninterventional patient registry indexed as PV4842 with the local ethics committee.
SETTING: The study is set in a hospitalized and ambulatory setting. PATIENTS: 148 patients with adult-onset craniopharyngioma were recruited from 8 centers, 22 prospectively and 126 retrospectively. Mean follow-up was 31 months.
INTERVENTIONS: No interventions performed. MAIN OUTCOME MEASURES: Complications, symptoms, body mass index (BMI), and quality of life (QoL; EORTC QLQ C30 and BN20) were recorded preoperatively and at follow-up. The hypotheses tested were generated after data collection.
RESULTS: Complications were more frequent after transcranial than transsphenoidal approaches (31 % vs. 11%; P < 0.01). Preoperative obesity was present in 0% papillary and in 38% of all adamantinomatous craniopharyngiomas (P = 0.05), and diabetes insipidus was more frequent for papillary craniopharyngioma (36.8% vs. 16,7%; P < 0.05). Hormone deficits at follow-up were reduced in 16.9%, equal in 31.4%, and increased in 63.6% (P < 0.001). BMI increased from 28.7 ± 7.4 kg/m2 before surgery to 30.2 ± 7.4 kg/m2 at follow-up (P < 0.001). In QoL, a decrease of future uncertainty (62.5 vs. 36.8; P = 0.02) and visual disorders (38.9 vs. 12.0; P = 0.01) were observed in the prospective collective after surgery.
CONCLUSIONS: Adult craniopharyngioma is associated with a complex sociological and psychological burden and hypothalamic dysfunction, warranting further investigation and emphasizing the need for a wider treatment approach. © Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Year:  2020        PMID: 31589293     DOI: 10.1210/clinem/dgz043

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  Preoperative BMI Predicts Postoperative Weight Gain in Adult-onset Craniopharyngioma.

Authors:  Daisy Duan; Leen Wehbeh; Debraj Mukherjee; Amir H Hamrahian; Fausto J Rodriguez; Sachin Gujar; Adham M Khalafallah; Camille Hage; Patrizio Caturegli; Gary L Gallia; Rexford S Ahima; Nisa M Maruthur; Roberto Salvatori
Journal:  J Clin Endocrinol Metab       Date:  2021-03-25       Impact factor: 5.958

2.  Disease Control after Radiotherapy for Adult Craniopharyngioma: Clinical Outcomes from a Large Single-Institution Series.

Authors:  Michael S Rutenberg; Adam L Holtzman; Daniel J Indelicato; Soon Huh; Dinesh Rao; Peter J Fiester; Christopher G Morris; Daryoush Tavanaiepour; Robert J Amdur
Journal:  J Neurooncol       Date:  2022-03-12       Impact factor: 4.130

3.  Risk Factors for Hypothalamic Obesity in Patients With Adult-Onset Craniopharyngioma: A Consecutive Series of 120 Cases.

Authors:  Wei Wu; Quanya Sun; Xiaoming Zhu; Boni Xiang; Qiongyue Zhang; Qing Miao; Yongfei Wang; Yiming Li; Hongying Ye
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-28       Impact factor: 5.555

4.  Surgical aspects in craniopharyngioma treatment.

Authors:  Shingo Fujio; Tomoko Hanada; Masanori Yonenaga; Yushi Nagano; Mika Habu; Kazunori Arita; Koji Yoshimoto
Journal:  Innov Surg Sci       Date:  2020-10-30

Review 5.  Endocrine Disorder in Patients With Craniopharyngioma.

Authors:  Zihao Zhou; Sheng Zhang; Fangqi Hu
Journal:  Front Neurol       Date:  2021-12-02       Impact factor: 4.003

Review 6.  The effect of radiation therapy and chemotherapy on malignant craniopharyngioma: A review.

Authors:  Turki Elarjani; Meshari Rashed Alhuthayl; Hindi Alhindi; Imad N Kanaan
Journal:  Surg Neurol Int       Date:  2021-10-25

7.  Development and Validation of Predicting Nomograms for Craniopharyngioma: A Retrospective, Multiple-Center, Cohort Study.

Authors:  Dingkang Xu; Qingjie Wei; Zhe Li; Yan Hu; Peizhu Hu; Shengqi Zhao; Dengpan Song; Shixiong Lei; Mingchu Zhang; Qiang Gao; Longxiao Zhang; Fangbo Lin; Yuchao Zuo; Xianzhi Liu; Mengzhao Feng; Chunxiao Ma; Fuyou Guo
Journal:  Front Oncol       Date:  2021-07-12       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.